002275 logo

Guilin Sanjin Pharmaceutical Co., Ltd. Stock Price

SZSE:002275 Community·CN¥8.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

002275 Share Price Performance

CN¥14.88
0.13 (0.88%)
CN¥14.88
0.13 (0.88%)
Price CN¥14.88

002275 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Excellent balance sheet, good value and pays a dividend.

2 Risks
2 Rewards

Guilin Sanjin Pharmaceutical Co., Ltd. Key Details

CN¥2.1b

Revenue

CN¥582.7m

Cost of Revenue

CN¥1.5b

Gross Profit

CN¥1.0b

Other Expenses

CN¥507.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 30, 2025
0.86
72.57%
23.89%
19.4%
View Full Analysis

About 002275

Founded
1967
Employees
2567
CEO
Xun Zou
WebsiteView website
www.sanjin.com.cn

Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, and sale of traditional Chinese and natural medicines in China. The company primarily offers Guilin watermelon frost and lozenge, and Sanjin tablets under the Chinese TCM brand; and Naomaitai capsules, etc. It also produces TCM preparations. Guilin Sanjin Pharmaceutical Co., Ltd. was founded in 1967 and is headquartered in Guilin, China. Guilin Sanjin Pharmaceutical Co., Ltd. operates as a subsidiary of Guilin SanJin Group Co.,Ltd.

Recent 002275 News & Updates

Recent updates

No updates